skinny.

Latest / Lung Cancer Considered

FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC

FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC by IASLC

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.